Dexamethasone Reduces Postoperative Emesis by Decreasing PGF2α and LTC4 Levels

NCT01811199 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2013-03-14

No results posted yet for this study

Summary

Hypothesis: Dexamethasone reduces postoperative emesis in thyroidectomy and mastectomy patients.

Conditions

Sponsors & Collaborators

  • Marmara University

    lead OTHER

Principal Investigators

  • A.Ozdemir Aktan, MD,prof · Marmara University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2013-04-30
Completion
2013-05-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01811199 on ClinicalTrials.gov